Skip to content
healthcare.dev

AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE

NDC 45802-066, azelastine hydrochloride, fluticasone propionate, spray, metered, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-066
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
SPRAY, METERED
Route
NASAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208111
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-066 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZELASTINE HYDROCHLORIDE137 ug/1
  • FLUTICASONE PROPIONATE50 ug/1

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
45802-066-01458020066011 BOTTLE in 1 CARTON (45802-066-01) / 120 SPRAY, METERED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/625ffdd0-8486-49af-8e77-6aa663be5ac7
  • NADAC price for package 45802006601

    GET /v1/drugs/nadac/45802006601

Use it

Look up 45802-066 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-066 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-066. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.